Skip to main content
. Author manuscript; available in PMC: 2024 May 13.
Published in final edited form as: Int J Cancer. 2020 May 16;147(10):2677–2686. doi: 10.1002/ijc.33033

TABLE 1.

Prevalence of HPV35 among HPV-positive women ages 30 to 64 in the Persistence and Progression (PaP) Cohort at Kaiser Permanente Northern California by ethnicity

n HPV35+ Weighted percent (95% CI) Prevalence difference vs other women (95% CI) P-value
Total 8230 478 5.8 (5.2-6.3)
White 4142 237 5.6 (4.8-6.3) −0.4 (−1.5-0.7)   .3
Hispanic 1775   87 5.1 (4.0-6.2) −0.9 (−2.2-0.4)   .1
Asian 1609   62 4.0 (3.0-5.1) −2.2 (−3.4-0.9) <.01
African-American   704   92 12.1 (9.6-14.6) +7.0 (4.4-9.5) <.001

Note: Weight based upon sampling probability of the woman being selected for genotyping (higher for cases vs controls). Prevalence difference depicts the absolute higher or lower HPV35 prevalence among women in an ethnic group compared to all other women. Bold indicates Rao-Scott Chi-square test P-value < .0125, threshold used to account for multiple comparisons. In a test for the pairwise comparison using Poisson regression model, the f-statistic is 18.62 and the global P-value is <.0001.